Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

China flag China · Delayed Price · Currency is CNY
29.53
-0.38 (-1.27%)
Apr 28, 2026, 3:00 PM CST
Market Cap13.08B +73.2%
Revenue (ttm)910.06M +38.3%
Net Income50.96M
EPS0.13
Shares Out442.94M
PE Ratio236.24
Forward PEn/a
Dividend0.06 (0.19%)
Ex-Dividend Daten/a
Volume8,201,929
Average Volume10,096,906
Open30.03
Previous Close29.91
Day's Range29.29 - 30.38
52-Week Range16.07 - 44.99
Beta0.81
RSI44.52
Earnings DateMar 31, 2026

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research and development of original small molecule drugs. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for the treatment of peripheral T-cell lymphoma and advanced hormone receptor-positive breast cancer; Chiglitazar Sodium, a PPAR pan-agonist for the treatment of metabolic diseases; and Chiauranib, a triple-pathway tumor-targeting inhibitor. It is also developing CS23546, a small-molecule PD-L1 inhibitor; CS231295, a brain-penetrant Aurora B selectiv... [Read more]

Sector Healthcare
Founded 2001
Employees 1,002
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688321
Full Company Profile

Financial Performance

Financial Statements